A new study finds AI can potentially detect artery calcification in routine mammograms, helping identify women at risk of ...

Cancer Horoscope: Welcome, nurturing Cancer! You are celebrated for your deep empathy, intuitive nature, and fierce ...

A positive story for those going through cancer treatment. The Houston-based non-profit CanCare is stepping in to fill the ...

The University of Oklahoma’s Native Nations Center for Tribal Policy Research has released a new Sovereign Report examining ...

Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial ...

ImmunityBio’s sBLA targets BCG-unresponsive papillary NMIBC without CIS, complementing the existing U.S. approval for CIS ...

The American Cancer Society predicts that 55,000 people or more will pass away from colorectal cancer this year, and doctors at United Hospital Center (UHC) in Bridgeport are raising awareness for ...

Are time commitments related to cancer care toxic? Depends on who you ask.The term “time toxicity” has become cancer jargon over the past few years, sparking research into how much time patients spend ...

"Patients do not want to be shielded from difficult treatment decisions," says Associate Professor Jannicke Rabben at Norway's University of Agder (UiA). "Even patients who say that the doctor knows ...

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...

Roche Holding said a drug combination including a new experimental breast-cancer treatment fell short of its primary ...

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...